Date | Time | Place | Session / Title | Role |
April 25 | 2:20 PM - 2:30 PM | Abstract Zone I, Level 3 | 1-1. DES & BVS [TCTAP A-063] Medium-term Clinical Outcomes of the Everolimus-eluting Bioresorbable Vascular Scaffold in Real-world Practice |
Abstract Presenter |
April 25 | 4:40 PM - 4:50 PM | Abstract Zone II, Level 3 | 2-3. Imaging & Physiology [TCTAP A-089] Discordant Fractional Flow Reserve and Coronary Flow Reserve Values on Long Term Patient Outcomes |
Abstract Presenter |